Physician
Mercy Hospital South
Mercy Hospital South was paid $22.01M by Medicaid between Jan 2018 and Dec 2024, across 120 billing codes. Its largest line is 99285, emergency room visit (most serious) — 35% of everything it billed.
33Billing provider infoMERCY HOSPITAL SOUTH
SAINT LOUIS, MO 63128
SAINT LOUIS, MO 63128
33aNPI1568481984assigned 07/18/2006
33bProvider typeEmergency Medicine Physician
28Total paid$22.01M
24GClaims195,692
24DCodes billed120
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Emergency Medicine Physician providers in Missouri
Rank by total paid#2 of 571
Median peer was paid$14K
This provider vs. median1,558×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 29,219 | $4.56M | |
| 2019 | 25,352 | $3.19M | |
| 2020 | 18,180 | $1.64M | |
| 2021 | 23,205 | $1.61M | |
| 2022 | 26,539 | $2.71M | |
| 2023 | 37,309 | $4.12M | |
| 2024incomplete | 35,888 | $4.17M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 35% | 43,396 | 34,313 | $7.60M |
| X4011 | State-specific procedure code | 17% | 18,676 | 17,613 | $3.79M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 11% | 17,632 | 13,692 | $2.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 7.8% | 14,794 | 11,683 | $1.71M |
| Y7506 | 6.0% | 11,974 | 10,221 | $1.33M | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 6.0% | 28,411 | 26,229 | $1.32M |
| 80053 | Comprehensive metabolic panel | 5.3% | 24,737 | 23,193 | $1.17M |
| 81001 | 1.3% | 2,369 | 2,202 | $282K | |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 5,836 | 5,485 | $254K |
| X4006 | <1% | 370 | 274 | $191K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 1,568 | 1,513 | $161K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,002 | 205 | $149K |
108 more codes
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 976 | $142K |
| 64483 | <1% | 333 | $139K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 1,251 | $107K |
| 64493 | <1% | 239 | $106K | |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | <1% | 268 | $76K |
| 84703 | <1% | 254 | $66K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,902 | $63K |
| X4003 | <1% | 1,117 | $59K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 642 | $57K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 554 | $49K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,095 | $48K |
| 64635 | <1% | 44 | $47K | |
| 83690 | <1% | 392 | $43K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 595 | $36K |
| G0378 | Hospital observation service, per hour | <1% | 199 | $35K |
| 84484 | <1% | 1,439 | $33K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 104 | $32K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 145 | $28K |
| 71045 | Radiologic examination, chest; single view | <1% | 530 | $26K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 296 | $26K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 623 | $25K |
| 87070 | <1% | 271 | $24K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 229 | $19K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 94 | $19K |
| 43275 | <1% | 12 | $19K | |
| Y7507 | <1% | 281 | $17K | |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 388 | $16K |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 308 | $15K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 106 | $15K |
| 90870 | <1% | 47 | $14K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 40 | $13K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 273 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 151 | $10K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 627 | $10K |
| 80061 | Lipid panel | <1% | 330 | $9K |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 49 | $7K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 111 | $7K |
| J3490 | Unclassified drugs | <1% | 2,642 | $6K |
| 92587 | <1% | 63 | $5K | |
| 92567 | <1% | 159 | $4K | |
| 84144 | <1% | 79 | $3K | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 70 | $3K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 77 | $3K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 12 | $3K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 122 | $2K |
| 84702 | <1% | 24 | $2K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 25 | $2K |
| 93017 | <1% | 13 | $2K | |
| 85652 | <1% | 92 | $2K | |
| 97597 | <1% | 36 | $2K | |
| 86140 | <1% | 78 | $2K | |
| 20610 | <1% | 14 | $2K | |
| 93798 | <1% | 78 | $2K | |
| 80081 | <1% | 12 | $2K | |
| 86850 | <1% | 12 | $1K | |
| 86900 | <1% | 12 | $1K | |
| 86901 | <1% | 12 | $1K | |
| 81002 | <1% | 17 | $1K | |
| 86803 | <1% | 12 | $1K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 30 | $1K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 14 | $1K |
| 82077 | <1% | 82 | $1K | |
| 85027 | <1% | 122 | $1K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 13 | $1K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $1K |
| 98941 | Chiropractic manipulative treatment; spinal, 3-4 regions | <1% | 29 | $656.05 |
| 88342 | <1% | 12 | $572.97 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 27 | $394.82 |
| 80076 | <1% | 55 | $263.00 | |
| 82043 | <1% | 12 | $200.67 | |
| 82570 | <1% | 12 | $199.23 | |
| 83605 | <1% | 72 | $164.52 | |
| 82803 | <1% | 56 | $156.50 | |
| G0381 | Level 2 hospital emergency department visit provided in a type b emergency department; (the ed must meet at least one of the following requirements: (1) it is licensed by the state in which it is located under applicable state law as an emergency room or emergency department; (2) it is held out to the public (by name, posted signs, advertising, or other means) as a place that provides care for emergency medical conditions on an urgent basis without requiring a previously scheduled appointment; or (3) during the calendar year immediately preceding the calendar year in which a determination under 42 cfr 489.24 is being made, based on a representative sample of patient visits that occurred during that calendar year, it provides at least one-third of all of its outpatient visits for the treatment of emergency medical conditions on an urgent basis without requiring a previously scheduled appointment) | <1% | 12 | $153.72 |
| 36591 | <1% | 90 | $150.34 | |
| 82962 | <1% | 154 | $93.68 | |
| 82330 | <1% | 26 | $73.77 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,012 | $72.25 |
| 85610 | <1% | 74 | $65.80 | |
| 76937 | <1% | 13 | $41.42 | |
| 83735 | <1% | 12 | $24.12 | |
| 82375 | <1% | 13 | $20.80 | |
| 83050 | <1% | 13 | $13.12 | |
| 85018 | <1% | 26 | $12.76 | |
| 87340 | <1% | 13 | $8.26 | |
| J2704 | Injection, propofol, 10 mg | <1% | 52 | $3.58 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 891 | $0.68 |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | 0% | 147 | $0.00 |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | 0% | 53 | $0.00 |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 591 | $0.00 |
| J7120 | Ringers lactate infusion, up to 1000 cc | 0% | 27 | $0.00 |
| 99152 | 0% | 208 | $0.00 | |
| C1757 | Catheter, thrombectomy/embolectomy | 0% | 72 | $0.00 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 0% | 15 | $0.00 |
| 81025 | 0% | 13 | $0.00 | |
| Q9966 | Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | 0% | 44 | $0.00 |
| A4649 | Surgical supply; miscellaneous | 0% | 26 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 383 | $0.00 |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 91 | $0.00 |
| J2370 | Injection, phenylephrine hcl, up to 1 ml | 0% | 30 | $0.00 |
| C1769 | Guide wire | 0% | 84 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 65 | $0.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 12 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 56 | $0.00 |
| 64494 | 0% | 19 | $0.00 | |
| 74330 | 0% | 16 | $0.00 | |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 37 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialSTURGEON, JONATHAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Professional Pharmacy Services INC | Florence, SC | $1.61M |
| Mercy Hospital South | Saint Louis, MO | $61K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.